VisionQuest Biomedical ^Companies

VisionQuest Biomedical is a medical device company founded in 2007 with the goal of preventing blindness and improving diabetes care. They use artificial intelligence to develop and commercialize advanced technologies. Their flagship product, EyeStar, is a software application that diagnoses diabetic retinopathy, while Aspire detects malarial retinopathy. Their latest innovation, i-RxTherm, aims to detect early-stage diabetic disease in areas beyond the eyes. VisionQuest Biomedical's mission is to create and deploy image-based technologies that improve access to healthcare for millions of people worldwide, particularly in the areas of diabetes and eye care.